Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR

Clinical trial NCT00574379 · COMPLETED

Trial details

NCT number: NCT00574379
Sponsor: Faes Farma, S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis Hay Fever Allergic Conjunctivitis Hypersensitivity

Start date: 2007-12-01
Primary completion: 2008-03-01
Enrollment: 805

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.